ahlam1399
07-18-2016, 11:19 AM
AstraZeneca?s lung cancer drug meets main goal in late-stage trial
(Reuters) - AstraZeneca Plc said its experimental lung cancer drug Tagrisso met its main goal in a late-stage study.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=jy47GwLwqkc:Szm6UxMTCZw:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=jy47GwLwqkc:Szm6UxMTCZw:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=jy47GwLwqkc:Szm6UxMTCZw:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=jy47GwLwqkc:Szm6UxMTCZw:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=jy47GwLwqkc:Szm6UxMTCZw:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/jy47GwLwqkc
(Reuters) - AstraZeneca Plc said its experimental lung cancer drug Tagrisso met its main goal in a late-stage study.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=jy47GwLwqkc:Szm6UxMTCZw:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=jy47GwLwqkc:Szm6UxMTCZw:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=jy47GwLwqkc:Szm6UxMTCZw:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=jy47GwLwqkc:Szm6UxMTCZw:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=jy47GwLwqkc:Szm6UxMTCZw:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/jy47GwLwqkc